Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRATA Skin Sciences, Inc. Director's Dealing 2013

Nov 13, 2013

35146_dirs_2013-11-13_f2538aad-7c6b-4652-93fd-1cca0d260a0c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MELA SCIENCES, INC. /NY (MELA)
CIK: 0001051514
Period of Report: 2013-11-11

Reporting Person: Crane Rosemary A (Director, CEO and President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-11-11 Stock Options $0.70 A 400000 Acquired 2023-11-11 Common Stock (400000) Direct

Footnotes

F1: Ms. Crane received options to purchase up to 400,000 shares of the Company's stock and will vest in three equal installments on November 11, 2014, November 11, 2015 and November 11, 2016.